You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMO-02-MD-2-003

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib)

Enrolling by invitation
  • Congenital Myotonic Dystrophy
  • Little Rock, Arkansas
  • +10 more
Nov 15, 2021

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib, Placebo)

Recruiting
  • Congenital Myotonic Dystrophy
  • Little Rock, Arkansas
  • +14 more
Aug 11, 2022

DLBCL, DLBCL Trial in Worldwide (Zilovertamab vedotin, Rituximab, Gemcitabine)

Recruiting
  • DLBCL
  • Diffuse Large B-Cell Lymphoma
  • Zilovertamab vedotin
  • +4 more
  • Whittier, California
  • +21 more
Nov 30, 2022

Nonalcoholic Steatohepatitis Trial in Fort Sam Houston (GR-MD-02, Placebo)

Completed
Has Results
  • Nonalcoholic Steatohepatitis
  • Fort Sam Houston, Texas
    Brooke Army Medical Center
Oct 6, 2020

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)

Recruiting
  • Hodgkin Disease
  • +2 more
  • pembrolizumab
  • Favezelimab
  • Gilbert, Arizona
  • +24 more
Aug 18, 2022

Psoriasis Trial in San Antonio (GR-MD-02)

Completed
Has Results
  • Psoriasis
  • San Antonio, Texas
    Brooke Army Medical Ctr.
Sep 3, 2020

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +3 more
  • Chandler, Arizona
  • +226 more
Aug 11, 2022

Melanoma Trial in Belgium, Spain (ECI-006)

Terminated
  • Melanoma
  • ECI-006
  • Antwerpen, Belgium
  • +8 more
Jun 16, 2021

Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)

Not yet recruiting
  • Amyloidosis; Systemic
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 11, 2023

Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)

Recruiting
  • Glioma
  • Rhenium Liposome Treatment
  • Dallas, Texas
  • +2 more
Nov 3, 2021

Healthy, Safety and Tolerability Trial in Cypress (DF-003, Placebo)

Recruiting
  • Healthy
  • Safety and Tolerability
  • Cypress, California
    Altasciences Clinical Los Angeles, Inc
Aug 9, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +34 more
Jan 25, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)

Active, not recruiting
  • Advanced Solid Tumors
  • AMG 994
  • AMG 404
  • Duarte, California
  • +16 more
Nov 16, 2022

Atopic Dermatitis Trial in Canada, United States (Ruxolitinib, Vehicle Cream)

Recruiting
  • Atopic Dermatitis
  • Birmingham, Alabama
  • +90 more
Dec 1, 2022

Treatment Resistant Depression Trial in New York (BPL-003)

Not yet recruiting
  • Treatment Resistant Depression
  • New York, New York
    New York State Psychiatric Institute
May 12, 2023

Diabetic Peripheral Neuropathy Trial in United States (Engensis, Placebo)

Recruiting
  • Diabetic Peripheral Neuropathy
  • Engensis
  • Placebo
  • Phoenix, Arizona
  • +15 more
Nov 3, 2022

Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +118 more
Aug 22, 2022

Palmoplantar Pustulosis Trial in Worldwide (RIST4721, Placebo)

Recruiting
  • Palmoplantar Pustulosis
  • Birmingham, Alabama
  • +35 more
Aug 8, 2022

HER2-ve Metastatic Breast Cancer, Germline BRCA1/2 Mutations, Somatic BRCA1/2 Mutations Trial in Worldwide (Olaparib)

Completed
Has Results
  • HER2-ve Metastatic Breast Cancer
  • +2 more
  • Towson, Maryland
  • +122 more
Dec 22, 2022

Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,

Recruiting
  • Chronic HBV Infection
  • Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
  • +2 more
  • Beijing, Beijing, China
  • +7 more
Feb 23, 2023

Myopia, Astigmatism Trial in Palo Alto (Wavefront-guided LASIK - Allegretto, Wavefront-guided LASIK - AMO)

Completed
  • Myopia
  • Astigmatism
  • Wavefront-guided LASIK - Allegretto
  • Wavefront-guided LASIK - AMO
  • Palo Alto, California
    Byers Eye Institute at Stanford
Apr 3, 2022

Neovascular Age-related Macular Degeneration Trial (FT-003)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • FT-003
  • (no location specified)
Nov 21, 2022